Relmada Therapeutics RLMD
NASDAQ RLMD
$3.35 -0.01 (-0.30%)
As of: Oct 21, 2026 · 11:41 AM EDT

Relmada Therapeutics (RLMD) Revenue (2012 - 2023)

Updated

Relmada Therapeutics' Revenue was $5,129 in FY2013, down 35.4% from $7,941 in FY2012.

Analysis

Relmada Therapeutics (RLMD) Revenue (2012 - 2023) Analysis & Trends

  • Per Business Quant data, Revenue in earlier years was $7,941 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 16.99 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 15.03 Bn
10 Relmada Therapeutics 377.02 Mn -181.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 540,923.00
Dec 31, 2022 1.08 Mn
Sep 30, 2022 265,963.00
Jun 30, 2022 411,835.00
Mar 31, 2022 314,927.00
Dec 31, 2021 35,964.00
Sep 30, 2021 -39,301.00
Jun 30, 2021 -30.10 Mn
Mar 31, 2021 -35.76 Mn
Dec 31, 2020 224,268.00
Sep 30, 2020 363,300.00
Jun 30, 2020 -8.39 Mn
Mar 31, 2020 -13.19 Mn
Dec 31, 2019 849,211.00
Sep 30, 2019 37,916.00
Mar 31, 2019 15,939.00
Dec 31, 2018 -139,765.00
API Access

Relmada Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RLMD&period=max&api_key=YOUR_API_KEY